Gerdtsson AS, Matos Rodrigues J de, Eskelund CW, Husby S, Grønbæk K, Räty R, Kolstad A, Geisler C, Porwit A, Jerkeman M, Ek S. Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors. Haematologica 2023;108(4):1092-1104; https://doi.org/10.3324/haematol.2022.281420.